NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE127252 Query DataSets for GSE127252
Status Public on Feb 28, 2019
Title Effect of sulforaphane and 5-aza-2'-deoxycytidine on melanoma cell growth
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Background: UV exposure-induced oxidative stress is implicated as the driving mechanism for melanoma. Increased oxidative stress results in DNA damage and epigenetic modifications. We wondered whether a low dose of antioxidant could attenuate the oxidative stress of and help cells respond to epigenetic modification treatment at a lower dose. Sulforaphane (SFN) is a natural bioactivated product of the cruciferous family and is known as an antioxidant. We investigated the combinational effect of SFN and epigenetic modification drug, 5-aza-2'-deoxycytidine (DAC), on metastatic melanoma growth.
Methods: Cell growth characteristics, RNA-seq and histone post-translational modification markers (PTMs) were compared in single and combination treatments.
Results: We found increased cell growth inhibition and changes in gene expression profiles which includes a key immuno-regulator cytokine, C-C motif ligand 5 (CCL-5) gene expression upon combinational treatments. There was no significant difference in detectable histone PTMs between treatments.
Conclusions: These results indicate a potential combinational effect of a dietary antioxidant and an FDA-approved epigenetic drug in controlling melanoma growth. The long-term goal of the current study is to find the therapeutic role of the dietary antioxidant SFN as a supporting drug for targeted epigenetic treatment with DAC in controlling melanoma growth.
 
Overall design mRNA profiles of mouse B16F10 melanoma cells treated with DMSO (control) , DAC, SFN, or combination treatment (DAC + SFN) were generated by deep sequencing using illumina's NextSeq 500 instrument (75bp SE reads). Three independent biological repeats were performed for all sample groups.
 
Contributor(s) Chiang T, Koss BS, Su LJ, Washam CL, Byrum SD, Storey A, Tackett AJ
Citation(s) 31252639
Submission date Feb 27, 2019
Last update date Oct 21, 2019
Contact name Ravi W. Sun
E-mail(s) RSun@uams.edu
Organization name University of Arkansas for Medical Sciences
Department Department of Otolaryngology - Head and Neck Surgery
Street address 4301 W Markham St
City Little Rock
State/province Arkansas
ZIP/Postal code 72205
Country USA
 
Platforms (1)
GPL19057 Illumina NextSeq 500 (Mus musculus)
Samples (12)
GSM3633209 CON_rep1
GSM3633210 CON_rep2
GSM3633211 CON_rep3
Relations
BioProject PRJNA524486
SRA SRP187004

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE127252_RAW.tar 2.4 Mb (http)(custom) TAR (of TXT)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap